Mucormycosis Survivors in Central India Face Heavy Treatment Burden and Post-Discharge Adversities
A two-year follow-up of 108 mucormycosis patients in Central India reveals heavy antifungal and antibiotic prescribing, frequent adverse drug reactions, ...
